Published in Blood on August 30, 2012
Transcriptional profiling of mRNAs and microRNAs in human bone marrow precursor B cells identifies subset- and age-specific variations. PLoS One (2013) 0.79
CD137 ligand reverse signaling skews hematopoiesis towards myelopoiesis during aging. Aging (Albany NY) (2013) 0.78
B cells in the aging immune system: time to consider B-1 cells. Ann N Y Acad Sci (2015) 0.76
B Cell Development in the Bone Marrow Is Regulated by Homeostatic Feedback Exerted by Mature B Cells. Front Immunol (2016) 0.75
Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature (2005) 11.23
Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev (2006) 10.24
Clonal selection and learning in the antibody system. Nature (1996) 9.58
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature (2011) 8.45
Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age. Nature (2007) 7.72
BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice. Nat Genet (2004) 6.85
The aging of hematopoietic stem cells. Nat Med (1996) 6.67
Understanding the odd science of aging. Cell (2005) 6.50
Cell intrinsic alterations underlie hematopoietic stem cell aging. Proc Natl Acad Sci U S A (2005) 6.32
Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood (2004) 5.86
Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine (2005) 5.55
Aging hematopoietic stem cells decline in function and exhibit epigenetic dysregulation. PLoS Biol (2007) 5.48
The influence of age on T cell generation and TCR diversity. J Immunol (2005) 4.36
Doubling of world population unlikely. Nature (1997) 4.07
Functionally distinct hematopoietic stem cells modulate hematopoietic lineage potential during aging by a mechanism of clonal expansion. Proc Natl Acad Sci U S A (2010) 3.41
A differentiation checkpoint limits hematopoietic stem cell self-renewal in response to DNA damage. Cell (2012) 3.21
B-cell targeting in rheumatoid arthritis and other autoimmune diseases. Nat Rev Immunol (2006) 3.20
Dendritic cell homeostasis. Blood (2009) 3.18
Genotoxic stress abrogates renewal of melanocyte stem cells by triggering their differentiation. Cell (2009) 2.99
Heterogeneity and hierarchy within the most primitive hematopoietic stem cell compartment. J Exp Med (2010) 2.98
Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age. Proc Natl Acad Sci U S A (2011) 2.96
Rejuvenation of regeneration in the aging central nervous system. Cell Stem Cell (2012) 2.91
Acute myeloid leukemia: epidemiology and etiology. Cancer (2006) 2.82
Opposing roles for p16Ink4a and p19Arf in senescence and ageing caused by BubR1 insufficiency. Nat Cell Biol (2008) 2.81
Homeostasis of peripheral B cells in the absence of B cell influx from the bone marrow. J Exp Med (2001) 2.57
Insights into thymic aging and regeneration. Immunol Rev (2005) 2.55
TNF family member B cell-activating factor (BAFF) receptor-dependent and -independent roles for BAFF in B cell physiology. J Immunol (2004) 2.51
B-cell responses to vaccination at the extremes of age. Nat Rev Immunol (2009) 2.50
Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus. JAMA (2006) 2.34
Biology of immune responses to vaccines in elderly persons. Clin Infect Dis (2008) 2.32
The aging of the immune system. Transpl Int (2009) 2.32
A new mechanism for the aging of hematopoietic stem cells: aging changes the clonal composition of the stem cell compartment but not individual stem cells. Blood (2008) 2.23
Toll-like receptor 7 (TLR7)-driven accumulation of a novel CD11c⁺ B-cell population is important for the development of autoimmunity. Blood (2011) 2.20
The decline in B lymphopoiesis in aged mice reflects loss of very early B-lineage precursors. J Immunol (2003) 2.17
B-cell diversity decreases in old age and is correlated with poor health status. Aging Cell (2008) 2.15
Hematopoietic stem cell heterogeneity takes center stage. Cell Stem Cell (2012) 1.94
Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies. J Clin Invest (2011) 1.94
Aging down-regulates the transcription factor E2A, activation-induced cytidine deaminase, and Ig class switch in human B cells. J Immunol (2008) 1.94
Thymic involution and immune reconstitution. Trends Immunol (2009) 1.91
Epidemiology and consequences of sarcopenia. J Nutr Health Aging (2009) 1.85
A B-cell subset uniquely responsive to innate stimuli accumulates in aged mice. Blood (2011) 1.84
B-cell depletion reactivates B lymphopoiesis in the BM and rejuvenates the B lineage in aging. Blood (2011) 1.82
Developmental regulation of B lymphocyte immune tolerance compartmentalizes clonal selection from receptor selection. Cell (1998) 1.78
Increased superoxide in vivo accelerates age-associated muscle atrophy through mitochondrial dysfunction and neuromuscular junction degeneration. FASEB J (2009) 1.78
Accumulation of DNA damage in hematopoietic stem and progenitor cells during human aging. PLoS One (2011) 1.62
B cell maintenance in aged mice reflects both increased B cell longevity and decreased B cell generation. J Immunol (1999) 1.54
Deaths: leading causes for 2003. Natl Vital Stat Rep (2007) 1.54
Consequences of sarcopenia. Clin Geriatr Med (2011) 1.51
The effect of age on the B-cell repertoire. J Clin Immunol (2000) 1.47
Ageing, autoimmunity and arthritis: senescence of the B cell compartment - implications for humoral immunity. Arthritis Res Ther (2004) 1.44
Requirement for invariant chain in B cell maturation and function. Science (1996) 1.41
Aging-dependent exclusion of antigen-inexperienced cells from the peripheral B cell repertoire. J Immunol (2002) 1.39
Stem cell heterogeneity: implications for aging and regenerative medicine. Blood (2012) 1.38
Altered antibody response to influenza H1N1 vaccine in healthy elderly people as determined by HI, ELISA, and neutralization assay. J Med Virol (1998) 1.34
Age changes in stem cells of murine small intestinal crypts. Exp Cell Res (1998) 1.32
Proliferation kinetics and the lifespan of B cells in central and peripheral lymphoid organs. Curr Opin Immunol (1991) 1.31
Effects of aging on the common lymphoid progenitor to pro-B cell transition. J Immunol (2006) 1.30
Changes in life expectancy 1900-1990. Am J Clin Nutr (1992) 1.26
Acquired hematopoietic stem cell defects determine B-cell repertoire changes associated with aging. Proc Natl Acad Sci U S A (2008) 1.25
Independent homeostatic regulation of B cell compartments. Eur J Immunol (1997) 1.19
Age-related CD8+ T cell clonal expansions express elevated levels of CD122 and CD127 and display defects in perceiving homeostatic signals. J Immunol (2006) 1.19
Human skin stem cells and the ageing process. Exp Gerontol (2008) 1.15
Decreased E12 and/or E47 transcription factor activity in the bone marrow as well as in the spleen of aged mice. J Immunol (2003) 1.13
Receptor editing in positive and negative selection of B lymphopoiesis. J Immunol (2004) 1.10
Contribution of hypoxia to Alzheimer's disease: is HIF-1alpha a mediator of neurodegeneration? Cell Mol Life Sci (2009) 1.07
Functional and physiological characteristics of the aging skin. Aging Clin Exp Res (2008) 1.07
Morphological changes in nerve cells during normal aging. Brain Struct Funct (2011) 1.04
Vaccine effectiveness in older individuals: what has been learned from the influenza-vaccine experience. Ageing Res Rev (2010) 1.03
Reduced EBF expression underlies loss of B-cell potential of hematopoietic progenitors with age. Aging Cell (2010) 1.02
Aging and impaired immunity to influenza viruses: implications for vaccine development. Hum Vaccin (2011) 1.02
Autologous stem-cell transplantation in refractory autoimmune diseases after in vivo immunoablation and ex vivo depletion of mononuclear cells. Arthritis Res (2000) 1.00
Phenotype of lymphocyte subsets after autologous peripheral blood stem cell transplantation. Bone Marrow Transplant (1997) 0.98
Regenerative capacity of adult cortical thymic epithelial cells. Proc Natl Acad Sci U S A (2012) 0.98
Regeneration of the immunoglobulin heavy-chain repertoire after transient B-cell depletion with an anti-CD20 antibody. Arthritis Res Ther (2005) 0.97
Tracing thymic output in older individuals. Clin Exp Immunol (2010) 0.97
Impaired rearrangement of IgH V to DJ segments in bone marrow Pro-B cells from old mice. Cell Immunol (2003) 0.96
Impaired light chain allelic exclusion and lack of positive selection in immature B cells expressing incompetent receptor deficient of CD19. J Immunol (2002) 0.93
Age-associated changes in thymopoiesis. Springer Semin Immunopathol (2002) 0.93
B cells and aging: balancing the homeostatic equation. Exp Gerontol (2007) 0.93
Impaired regeneration of the peripheral B cell repertoire from bone marrow following lymphopenia in old mice. Eur J Immunol (2001) 0.92
B cell development in aging mice: lessons from mathematical modeling. Int Immunol (2005) 0.90
Red blood cells. Int J Biochem Cell Biol (2002) 0.88
Post-irradiation regeneration of early B-lymphocyte precursor cells in mouse bone marrow. Immunology (1989) 0.87
Modification of ligand-independent B cell receptor tonic signals activates receptor editing in immature B lymphocytes. J Biol Chem (2003) 0.86
Senescent B lymphopoiesis is balanced in suppressive homeostasis: decrease in interleukin-7 and transforming growth factor-beta levels in stromal cells of senescence-accelerated mice. Exp Biol Med (Maywood) (2004) 0.85
Cell based approaches for myocardial regeneration and artificial myocardium. Curr Stem Cell Res Ther (2007) 0.85
Reversing T cell immunosenescence: why, who, and how. Age (Dordr) (2012) 0.85
Chronic B cell deficiency from birth prevents age-related alterations in the B lineage. J Immunol (2011) 0.84
Aging impairs murine B cell differentiation and function in primary and secondary lymphoid tissues. Aging Dis (2011) 0.84
Age-dependent increase of memory B cell response to cytomegalovirus in healthy adults. Exp Gerontol (2012) 0.83
B cell maturation and selection at the marrow-periphery interface. Immunol Res (1998) 0.81
Reversing B cell aging. Aging (Albany NY) (2011) 0.80
Regulation and localization of lymphocyte production in the bone marrow. Ciba Found Symp (1981) 0.79
Antigen receptor signaling competence and the determination of B cell fate in B-lymphopoiesis. Histol Histopathol (2005) 0.78
Immunoglobulin transgenes in B lymphocyte development, tolerance, and autoimmunity. Curr Dir Autoimmun (1999) 0.78
E47 retroviral rescue of intrinsic B-cell defects in senescent mice. Aging Cell (2011) 0.78
Old mice retain bone marrow B1 progenitors, but lose B2 precursors, and exhibit altered immature B cell phenotype and light chain usage. Mech Ageing Dev (2009) 0.78
Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature (2011) 9.71
Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone. J Clin Oncol (2012) 3.59
EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation. Cancer Cell (2013) 3.13
Activation of natural regulatory T cells by IgG Fc-derived peptide "Tregitopes". Blood (2008) 2.50
Arf6 and microtubules in adhesion-dependent trafficking of lipid rafts. Nat Cell Biol (2007) 2.23
Loss of BAF250a (ARID1A) is frequent in high-grade endometrial carcinomas. J Pathol (2011) 1.91
Immunogenicity of protein therapeutics. Trends Immunol (2007) 1.90
Mechanism-based epigenetic chemosensitization therapy of diffuse large B-cell lymphoma. Cancer Discov (2013) 1.90
Impact of concordant and discordant bone marrow involvement on outcome in diffuse large B-cell lymphoma treated with R-CHOP. J Clin Oncol (2011) 1.86
Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing. Blood (2013) 1.84
Induction of tolerance to factor VIII inhibitors by gene therapy with immunodominant A2 and C2 domains presented by B cells as Ig fusion proteins. Blood (2005) 1.71
Variability in DNA methylation defines novel epigenetic subgroups of DLBCL associated with different clinical outcomes. Blood (2014) 1.64
Identification of an essential Francisella tularensis subsp. tularensis virulence factor. Infect Immun (2008) 1.50
Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trial. Blood (2012) 1.49
B cells "transduced" with TAT-fusion proteins can induce tolerance and protect mice from diabetes and EAE. Clin Immunol (2011) 1.44
Simple quality improvement interventions reduce unnecessary intravascular device dwell time. Infect Control Hosp Epidemiol (2008) 1.40
Robust Fitting of a Weibull Model with Optional Censoring. Comput Stat Data Anal (2013) 1.39
Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B-cell lymphoma. Blood (2014) 1.26
Francisella tularensis subsp. tularensis Schu S4 disulfide bond formation protein B, but not an RND-type efflux pump, is required for virulence. Infect Immun (2008) 1.23
B-cell-delivered gene therapy induces functional T regulatory cells and leads to a loss of antigen-specific effector cells. Mol Ther (2010) 1.17
Immunodominant T-cell epitopes in the factor VIII C2 domain are located within an inhibitory antibody binding site. Thromb Haemost (2004) 1.17
RalA-exocyst complex regulates integrin-dependent membrane raft exocytosis and growth signaling. Curr Biol (2009) 1.16
Gene transfer of Ig-fusion proteins into B cells prevents and treats autoimmune diseases. J Immunol (2002) 1.15
The E3 ubiquitin ligase UBR5 is recurrently mutated in mantle cell lymphoma. Blood (2013) 1.15
Effect of HLA DR epitope de-immunization of Factor VIII in vitro and in vivo. Clin Immunol (2011) 1.14
Endothelial surface N-glycans mediate monocyte adhesion and are targets for anti-inflammatory effects of peroxisome proliferator-activated receptor γ ligands. J Biol Chem (2011) 1.09
Treatment of diabetes in NOD mice by gene transfer of Ig-fusion proteins into B cells: role of T regulatory cells. Cell Immunol (2006) 1.08
A novel retroviral gene therapy approach to inhibit specific antibody production and suppress experimental autoimmune encephalomyelitis induced by MOG and MBP. Clin Immunol (2004) 1.01
Analysis of FOXO1 mutations in diffuse large B-cell lymphoma. Blood (2013) 1.00
Tolerance induction by gene transfer to lymphocytes. Curr Gene Ther (2007) 1.00
Comprehensive miRNA sequence analysis reveals survival differences in diffuse large B-cell lymphoma patients. Genome Biol (2015) 0.99
Effect of B-cell depletion using anti-CD20 therapy on inhibitory antibody formation to human FVIII in hemophilia A mice. Blood (2010) 0.98
Mycobacterial Hsp65-IgG-expressing tolerogenic B cells confer protection against adjuvant-induced arthritis in Lewis rats. Arthritis Rheum (2007) 0.97
Tregitope update: mechanism of action parallels IVIg. Autoimmun Rev (2012) 0.97
B cells induce tolerance by presenting endogenous peptide-IgG on MHC class II molecules via an IFN-gamma-inducible lysosomal thiol reductase-dependent pathway. J Immunol (2008) 0.97
A role for thrombin in the initiation of the immune response to therapeutic factor VIII. Blood (2009) 0.97
In vitro and in vivo studies of IgG-derived Treg epitopes (Tregitopes): a promising new tool for tolerance induction and treatment of autoimmunity. J Clin Immunol (2012) 0.95
Requirement of the CXXC motif of novel Francisella infectivity potentiator protein B FipB, and FipA in virulence of F. tularensis subsp. tularensis. PLoS One (2011) 0.93
A factorial analysis of the combined effects of hydrogel fabrication parameters on the in vitro swelling and degradation of oligo(poly(ethylene glycol) fumarate) hydrogels. J Biomed Mater Res A (2013) 0.93
Mechanisms of gene therapy for tolerance: B7 signaling is required for peptide-IgG gene-transferred tolerance induction. J Immunol (2005) 0.93
Factor VIII inhibitors: risk factors and methods for prevention and immune modulation. Clin Rev Allergy Immunol (2009) 0.92
Tolerance induction via a B-cell delivered gene therapy-based protocol: optimization and role of the Ig scaffold. Cell Immunol (2005) 0.91
B-Cell Gene Therapy for Tolerance Induction: Host but Not Donor B-Cell Derived IL-10 is Necessary for Tolerance. Front Microbiol (2011) 0.90
Toll-like receptor 4-activated B cells out-compete Toll-like receptor 9-activated B cells to establish peripheral immunological tolerance. Proc Natl Acad Sci U S A (2012) 0.89
Application of IgG-derived natural Treg epitopes (IgG Tregitopes) to antigen-specific tolerance induction in a murine model of type 1 diabetes. J Diabetes Res (2013) 0.89
Potential application of tregitopes as immunomodulating agents in multiple sclerosis. Neurol Res Int (2011) 0.88
In vivo induction of tolerance by an Ig peptide is not affected by the deletion of FcR or a mutated IgG Fc fragment. Int Immunol (2002) 0.88
B-cell delivered gene transfer of human S-Ag-Ig fusion protein protects from experimental autoimmune uveitis. Clin Immunol (2005) 0.88
Tetracycline treatment retards the onset and slows the progression of diabetes in human amylin/islet amyloid polypeptide transgenic mice. Diabetes (2009) 0.87
Teaching tolerance: New approaches to enzyme replacement therapy for Pompe disease. Hum Vaccin Immunother (2012) 0.87
STAT6 controls the number of regulatory T cells in vivo, thereby regulating allergic lung inflammation. J Immunol (2013) 0.85
Modulation of CD8+ T cell responses to AAV vectors with IgG-derived MHC class II epitopes. Mol Ther (2013) 0.84
B-cell delivered gene therapy for tolerance induction: role of autoantigen-specific B cells. J Autoimmun (2010) 0.84
Bone marrow transplantation combined with gene therapy to induce antigen-specific tolerance and ameliorate EAE. Mol Ther (2005) 0.84
B cells with high side scatter parameter by flow cytometry correlate with inferior survival in diffuse large B-cell lymphoma. Am J Clin Pathol (2012) 0.84
Spontaneous diabetes in hemizygous human amylin transgenic mice that developed neither islet amyloid nor peripheral insulin resistance. Diabetes (2008) 0.83
Gene therapy for tolerance and vice versa: a case for hemophilia. Curr Opin Mol Ther (2010) 0.83
The transcription factor E26 transformation-specific sequence-1 mediates neointima formation in arteriovenous fistula. J Am Soc Nephrol (2013) 0.82
Characterization of porous polymethylmethacrylate space maintainers for craniofacial reconstruction. J Biomed Mater Res B Appl Biomater (2013) 0.80
Targeting endothelial adhesion molecule mRNA to control inflammation: novel insights into potential anti-inflammatory effects of IL-19. Focus on "Interleukin-19 decreases leukocyte-endothelial cell interactions by reduction in endothelial cell adhesion molecule mRNA stability". Am J Physiol Cell Physiol (2013) 0.79
Regulatory T cell epitopes (Tregitopes) in IgG induce tolerance in vivo and lack immunogenicity per se. J Leukoc Biol (2013) 0.79
B cell receptor signaling mediates immediate protection from Fas-induced apoptosis upstream of caspase activation through an atypical protein kinase C isozyme and de novo protein synthesis. Eur J Immunol (2003) 0.79
Tolerance induction in hemophilia A animal models: battling inhibitors with antigen-specific immunotherapies. Discov Med (2013) 0.78
Transplantation tolerance: one --- step towards the holy grail. Clin Immunol (2010) 0.77
Gene therapy and bone marrow stem-cell transfer to treat autoimmune disease. Trends Mol Med (2009) 0.77
Gene therapy with IgG-HY fusion proteins to reduce male-specific T-cell reactivity in vitro. Hum Gene Ther (2011) 0.76
Tolerance induction via B-cell delivered gene therapy. Methods Mol Biol (2012) 0.76
Cellular Immunology--mission statement. Cell Immunol (2015) 0.75